As of September 2024, Medifron DBT has a market cap of $50.89M. This makes Medifron DBT the world's 25175th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $56.03M | 47.51% |
2023 | $37.98M | -14.52% |
2022 | $44.43M | -55.51% |
2021 | $99.88M | -65.11% |
2018 | $286.31M | 36.21% |
2017 | $210.20M | 26.27% |
2016 | $166.47M | 27.59% |
2015 | $130.47M | 37.82% |
2014 | $94.67M | -19.20% |
2013 | $117.16M | -14.85% |
2012 | $137.60M | - |